Dr. Daruka Mahadevan earns national inventor award

Mays Cancer Center Annual Report
Daruka Mahadevan, M.D., Ph.D., chief of the Division of Hematology and Medical Oncology in the Department of Medicine, was recognized as a senior member of the National Academy of Inventors (NAI), a non-profit organization dedicated to encouraging inventors in academia.
At the University of Arizona Cancer Center, he discovered and designed a multi-targeted tyrosine kinase inhibitor, Amuvatinib (MP470), which has been tested in Phase I and II trials in solid tumor oncology. He has four families of patents to his name that include nine individual patents.